NDC 0591-0395
Pentazocine and naloxone
Pentazocine Hydrochloride And Naloxone Hydrochloride
Pentazocine and naloxone is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Pentazocine Hydrochloride; Naloxone Hydrochloride.
| Product ID | 0591-0395_23c66a22-a657-442f-8ea3-1f8dcde4a37e |
| NDC | 0591-0395 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pentazocine and naloxone |
| Generic Name | Pentazocine Hydrochloride And Naloxone Hydrochloride |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1997-05-21 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA074736 |
| Labeler Name | Actavis Pharma, Inc. |
| Substance Name | PENTAZOCINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
| Active Ingredient Strength | 50 mg/1; mg/1 |
| Pharm Classes | Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |